# Imaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/imaging

- Industry: Medical Devices & Equipment
- Headquarters: Nantong, China
- Website: www.first-imaging.com
- Total disclosed funding: $12M
- Latest round: Series B (Feb 13, 2026)
- Investors on record: 7

## About

Established in 2018 and based in Nantong, China, Jiangsu Imaging Medical Equipment Co., Ltd., trading under the name Imaging, is a medical device company specializing in the development and production of advanced 3D imaging systems. The company operates an 800-square-meter R&D center and a 5,000-square-meter production facility. Its 3D C-arm imaging systems are already deployed in multiple top-tier hospitals across China.  In February2026, Imaging raised a series B+ funding from Nantong Investment Management, Zhongqi Asset Management., Sichuan Development Industry Led Equity Investment Fund Management, SB China Venture Capital, Great Stone Capital and other investors.

The company develops intraoperative 3D imaging systems and robotic imaging platforms. Its core product, the 3D C-arm, features compact design, flexible operation and multi-angle imaging capabilities. It enables real-time three-dimensional imaging during surgery and supports minimally invasive robotic-assisted procedures.

The company generates revenue through the sale of medical imaging equipment and related software to hospitals and healthcare institutions.

The series B+ funds raised will be primarily used for the market promotion of intelligent intraoperative imaging equipment and the research and development of digital consumable products.

## Funding rounds

- Series B, Feb 13, 2026 — SB China Venture Capital, Sichuan Development Securities Investment Fund Management, Nantong Investment Management, Great Stone Capital
- Series A, Aug 18, 2021, $10M — China Everbright
- Angel, May 15, 2018, $1.6M — Casstar Capital, Blue Bay Capital

## Investors

- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Angel
- Blue Bay Capital — Angel
- China Everbright (https://capitalatlas.ai/funds/china-everbright) — Series A
- SB China Venture Capital (https://capitalatlas.ai/funds/sb-china-venture-capital) — Series B
- Sichuan Development Securities Investment Fund Management (https://capitalatlas.ai/funds/sichuan-development-securities-investment-fund-management) — Series B
- Nantong Investment Management — Series B
- Great Stone Capital (https://capitalatlas.ai/funds/great-stone-capital) — Series B